Indication
Stage IIIA Non-Small Cell Lung Cancer AJCC v7
3 clinical trials
3 products
2 drugs
Clinical trial
Three Pilot Studies of Stereotactic Body Radiation Therapy (SBRT) and Surgery in Non-small Cell Lung CancerStatus: Active (not recruiting), Estimated PCD: 2021-07-12
Clinical trial
A Phase I Study to Evaluate the Safety of Trigriluzole (FC-4157/BHV-4157) in Combination With PD-1 Blocking AntibodiesStatus: Completed, Estimated PCD: 2022-10-20
Product
Enzyme InhibitorDrug
T-VECDrug
mFOLFOX6Clinical trial
A Randomized Phase III Trial for Surgically Resected Early Stage Non-small Cell Lung Cancer: Crizotinib Versus Observation for Patients With Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion ProteinStatus: Recruiting, Estimated PCD: 2036-05-01
Product
Crizotinib